68 results
8-K
EX-1.1
ALRN
Aileron Therapeutics Inc
1 May 24
Entry into a Material Definitive Agreement
5:25pm
and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization, and (iv … and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually
DEFA14A
ALRN
Aileron Therapeutics Inc
31 Jan 24
Additional proxy soliciting materials
4:05pm
, virtually via the internet at www.meetnow.global/MTD5ADS To access the virtual meeting, you must have the information that is printed in the shaded bar
8-K
xkabxnf35eot41p
25 Jan 24
Other Events
7:00am
8-K
EX-10.2
00297u6lu0va98g ru
25 Jan 24
Other Events
7:00am
8-K
EX-10.4
njr4kz
25 Jan 24
Other Events
7:00am
8-K
EX-10.5
njed5e8eddyawf2rwf
25 Jan 24
Other Events
7:00am
8-K
EX-10.3
pc29rd
25 Jan 24
Other Events
7:00am
8-K
EX-10.1
cl1ukvqss rj3
25 Jan 24
Other Events
7:00am
8-K
fzt9v50b2doz7n9i07b
31 Oct 23
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
12:40pm
8-K
EX-2.1
ado54rr yzlc10l
31 Oct 23
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
12:40pm
8-K
EX-10.2
9f7ieoy
31 Oct 23
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
12:40pm
8-K
EX-10.1
jd8n9phe2
31 Oct 23
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
12:40pm
8-K
EX-99.2
1o0akuglc
31 Oct 23
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
12:40pm
8-K
EX-99.1
lm50lf4rult
31 Oct 23
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
12:40pm